KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in KalVista Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KALV is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 1
- −180 vs. Q1 2026
- Shares held
- 7
- −69.2M (−100.0%) vs. Q1 2026
- Total value
- $189
- −$1.39B (−100.0%) vs. Q1 2026
- New holders
- 1
- 0 more added
- Sold out
- 181
- 0 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 7 | $189 | 0.00% | +7 | New |
| VR Adviser, LLC | 0 | $0 | 0.00% | −6,474,485−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −4,961,108−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −4,768,712−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −4,573,530−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −3,795,897−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −2,876,407−100.0% | Sold out |
| Capital World Investors | 0 | $0 | 0.00% | −2,808,583−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,136,940−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −1,955,844−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,912,146−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −1,850,000−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −1,835,506−100.0% | Sold out |
| Vanguard Capital Management LLC | 0 | $0 | 0.00% | −1,830,467−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −1,820,954−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −1,509,920−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −1,450,000−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −1,264,023−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,236,000−100.0% | Sold out |
| Elmind Capital, LP | 0 | $0 | 0.00% | −1,021,300−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −996,235−100.0% | Sold out |
| Squadron Capital Management LLC | 0 | $0 | 0.00% | −985,100−100.0% | Sold out |
| Spruce Street Capital LP | 0 | $0 | 0.00% | −897,681−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −882,906−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −824,293−100.0% | Sold out |
| Emerald Mutual Fund Advisers Trust | 0 | $0 | 0.00% | −805,762−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −675,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −584,347−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −564,039−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −555,628−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −537,061−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −515,650−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −506,743−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −439,099−100.0% | Sold out |
| Catalio Capital Management, LP | 0 | $0 | 0.00% | −426,551−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −375,995−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −363,694−100.0% | Sold out |
| Vanguard Portfolio Management LLC | 0 | $0 | 0.00% | −362,900−100.0% | Sold out |
| SEB Asset Management AB | 0 | $0 | 0.00% | −351,305−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −323,451−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −315,537−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −286,916−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −286,046−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −276,750−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −276,391−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −267,402−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −245,993−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −244,261−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −229,984−100.0% | Sold out |
| F/M Investments LLC | 0 | $0 | 0.00% | −226,991−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −215,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −187,848−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −180,314−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −177,274−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −162,908−100.0% | Sold out |
| Nan Fung Trinity (HK) Ltd | 0 | $0 | 0.00% | −154,522−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −153,459−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −143,966−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −140,651−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −139,458−100.0% | Sold out |
| NEXTBio Capital Management LP | 0 | $0 | 0.00% | −131,796−100.0% | Sold out |
| Seven Fleet Capital Management LP | 0 | $0 | 0.00% | −128,487−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −125,049−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −107,262−100.0% | Sold out |
| Nuveen, LLC | 0 | $0 | 0.00% | −106,864−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −97,726−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −94,400−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −79,666−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −79,118−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −75,282−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −69,945−100.0% | Sold out |
| Swiss Life Asset Management Ltd | 0 | $0 | 0.00% | −21,885−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −64,249−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −59,986−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −57,296−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −56,192−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −54,900−100.0% | Sold out |
| CenterBook Partners LP | 0 | $0 | 0.00% | −53,264−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −50,792−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −49,927−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −47,469−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −46,760−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −43,775−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −42,576−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −41,149−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −38,857−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −37,572−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −35,123−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −35,119−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −34,743−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −33,776−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −33,750−100.0% | Sold out |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −32,453−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −31,542−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −29,367−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −33,580−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −26,850−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −25,660−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |